Evaluation of ColdZyme Mouth Spray against Common Cold in Elderly Care Personnel

ISSN Print: 2163-940X
ISSN Online: 2163-9418
www.scirp.net/journal/ojrd
E-mail: [email protected]

Citations

"Evaluation of ColdZyme Mouth Spray against Common Cold in Elderly Care Personnel"
written by Mats Clarsund, Christina Bråkenhielm Persson,
published by Open Journal of Respiratory Diseases, Vol.7 No.1, 2017

has been cited by the following article(s):

[1]	Early intervention with a glycerol throat spray containing cold-adapted cod trypsin after self-diagnosis of common cold: A randomised trial
	Plos one, 2022

[2]	ColdGuard™ in the prevention and management of the common cold
	2020

[3]	COLDZYME MUNSPRAY
	2019

[4]	in focus
	2002

[1]	The expanding role of protease therapeutics (2012–2026): from replacement therapies to immune system modulation and beyond Biochemical Journal, 2026 DOI:10.1042/BCJ20260152

[2]	ColdZyme® reduces viral load and upper respiratory tract infection duration and protects airway epithelia from infection with human rhinoviruses The Journal of Physiology, 2025 DOI:10.1113/JP288136

[3]	Does Trypsin Oral Spray (Viruprotect®/ColdZyme®) Protect against COVID-19 and Common Colds or Induce Mutation? Caveats in Medical Device Regulations in the European Union International Journal of Environmental Research and Public Health, 2021 DOI:10.3390/ijerph18105066